AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Submission of revised letter intimating about analysts / media meeting. In the earlier letter, timing of the meeting was mentioned as 3.45 AM instead of 3.45 PM hence, this revised letter. AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about analysts / media meet AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation of appointment of Senior Management Personnel of the Company
Aurobindo Pharma soars 4% on receiving USFDA approval to manufacture Fingolimod capsules
Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024 AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Submission of Press Release in connection with US FDA Approval for Fingolimod Capsules 0.5 mg. AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificates
Aurobindo Pharma trades down after 7 observations on Telangana unit from USFDA
Aurobindo Pharma Share Price | The USFDA inspected the injectable facility from 19th to 29th February 2024. AUROBINDO PHARMA LTD. - 524804 - Restarting Of Production In Terminally Sterilized Product Lines At Unit III Of Eugia Pharma Specialities Ltd. (A Wholly Owned Subsidiary)
Intimation about restarting of production in terminally sterilized product lines of Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Injectable Facility Of Eugia SEZ Private Limited
Intimation about completion of US FDA Inspection at injectable facility of Eugia SEZ Private Limited, a 100% step-down subsidiary of the Company. AUROBINDO PHARMA LTD. - 524804 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Trustee Services Ltd